Browse > Article
http://dx.doi.org/10.13048/jkm.16022

The Effects of Lycii Radicis Cortex on Inflammatory Response through an Oxidative Stress and AGEs-mediated Pathway in STZ-induced Diabetic Rats  

Jung, Yu Sun (Department of Internal Medicine of Korean Medicine, College of Korean Medicine, Dae-gu Haany University)
Shin, Hyeon Cheol (Department of Internal Medicine of Korean Medicine, College of Korean Medicine, Dae-gu Haany University)
Publication Information
The Journal of Korean Medicine / v.37, no.2, 2016 , pp. 62-75 More about this Journal
Abstract
Objectives: This study examined whether Lycii Radicis Cortex has an inhibitory effect on inflammatory response through an oxidative stress and advanced glycation endproducts (AGEs)-mediated pathway in streptozotocin (STZ)-induced type 1 diabetic rats. Methods: Lycii Radicis Cortex was orally administered to STZ-induced diabetic rats in doses of 80 or 160 mg/kg body weight/day for 2 weeks, and its effects were compared with those of diabetic control and normal rats. Results: The administration of Lycii Radicis Cortex decreased the elevated serum urea nitrogen and renal reactive oxygen species (ROS), and reduced the increased AGEs in the serum and kidney. The elevated protein expressions of nicotinamide adenine dinucleotide phosphate (NADPH) oxidase subunits in the kidney of diabetic control rats were significantly decreased after Lycii Radicis Cortex treatments. Moreover, the kidney of diabetic rats exhibited the up-regulation of receptor for AGEs (RAGE) and AGEs-related proteins; however, Lycii Radicis Cortex treatment also significantly reduced those expressions (excepted RAGE). In addition, the diabetic rats exhibited an up-regulation of the expression of proteins related to inflammation in the kidney, but Lycii Radicis Cortex administration reduced significantly the expression of the inflammatory proteins through the nuclear factor-kappa B (NF-${\kappa}B$) and activator protein-1 (AP-1) pathways. Conclusions: This study provides scientific evidence that Lycii Radicis Cortex exerts the antidiabetic effect by inhibiting the expressions of AGEs and NF-${\kappa}B$ in the STZ-induced diabetic rats.
Keywords
Lycii Radicis Cortex; Type 1 Diabetes; Oxidative Stress; Nuclear Factor-kappa B; Advanced Glycation Endproduct;
Citations & Related Records
Times Cited By KSCI : 3  (Citation Analysis)
연도 인용수 순위
1 Hess J, Anqel P, Schorpp-Kistner M. AP-1 subunits: quarrel and harmony among siblings. J Cell Sci. 2004;117:5965-73.   DOI
2 Peppa M, Vlassara H. Advanced glycation endproducts and diabetic complications: A general overview. Hormones. 2005;4:28-37.   DOI
3 Kikkawa R, Koya D, Haneda M. Progression of diabetic nephropathy. Am. J. Kidney Dis. 2013; 41:S19-21.
4 Forbes JM, Coughlan MT, Cooper ME. Oxidative stress as a major culprit in kidney disease in diabetes. Diabetes. 2008;57:1446-54.   DOI
5 Ruderman N, Wiliamson J, Brownlee M. Glucose and diabetic vascular disease. FASEB J. 1992;6:2905-14.   DOI
6 Schmidt AM, Yan SD, Stern DM. The dark side of glucose. Nature. 1995;Med1:1002-4.   DOI
7 Neeper M, Schmidt AM, Brett J, Yan SD, Wang F, Pan YC, et al. Cloning and expression of a cell surface receptor for advanced glycosylation endproducts of proteins. J. Biol Chem. 1992; 267:14998-15004.
8 Schmidt AM, Vianna M, Gerlach M, Brett J, Ryan J, Kao J, et al. Isolation and characterization of two binding proteins for advanced glycosylation endproducts from bovine lung which are present on the endothelial cell surface. J. Biol Chem. 1992;267:14987-97.
9 Wautier MP, Chappey O, Corda S, Stern DM, Schmidt AM, Wautier JL. Activation of NADPH oxidase by AGE links oxidant stress to altered gene expression via RAGE. Am. J. Physiol Endocrinol Metab. 2001;280:E685-94.   DOI
10 Simm A, MuEnch G, Seif F, Schenk O, Heidland A, Richter H, et al. Advanced glycation endproducts stimulate the MAP-kinase pathway in tubulus cell line LLC-PK1. FEBS Lett. 1997;410:481-4.   DOI
11 Wang FY, Luo JY. Dictionary of Traditional Chinese Materia Medica. Hunan:Hunan Science and Technology Press. 2006:167.
12 Ye Z, Haung Q, Ni HX, Wang D. Cortex Lycii Radicis extracts improve insulin resistance and lipid metabolism in obese-diabetic rats. Phytother Res. 2008;22:1665-70.   DOI
13 Funayama S, Yoshida K, Konno C, Hikino H. Structure of kukoamine A, a hypotensive principle of Lycium chinense root barks 1. Tetrahedron Lett. 1980;21:1355-6.   DOI
14 Chan JY, Leung PC, Che CT, Fung KP. Protective effects of an herbal formulation of Radix Astragali, Radix Condonopsis and Cortex Lycii on streptoaotocin-induced apaptosis in pancreatic beta-cells: an implication for its treatment of diabetes mellitus. Phytother. Rec. 2008;22:190-6.   DOI
15 Cho SH, Park EJ, Kim EO, Choi SW. Study on the hypochlesterolemic and actioxidative effects of tyramine derivatives from the root bark of Lycii Radicis Cortex. Nut. Rec. Pract. 2011;5:412-20.   DOI
16 Yamakoshi J, Kataoka S, Koga T, Ariga T. Proanthocyanidin-rich extract of grape seeds attenuated the development of aortic atherosclerosis in cholesterol-fed rabbits. Atherosclerosis. 1999; 142:139-49.   DOI
17 Jung YS, Park CH, Shin HC. Antioxidative effects of Lycium chinense Miller on cisplatin-induced nephrotoxicity in rats. Korean J. Orent. Int. Med. 2014;35:92-105.
18 Hou DX, Yanagita T, Uto T, Masuzaki S, Fujii M. Anthocyanidins inhibt cyclooxygenase-2 expression in LPS-evoked macrophages: structure-activity relationship and molecular mechanisms involved. Biochem. Pharmacol. 2005;70:417-25.   DOI
19 Jayaprakasam B, Vareed SK, Olson LK, Nair MG. Insulin secretion by bioactive anthocyanins and anthocyanidins present in fruits. J. Agric. Food Chem. 2005;53:28-31.   DOI
20 Ye X, Krohn RL, Liu W, Joshi SS, Kuszynski CA, McGinn TR, et al. The cytotoxic effects of n novel IH636 grape seed proanthocyanidin extract on cultured human cancer cells. Mol. Cell. Biochem. 1999;196:99-108.   DOI
21 Kim CM, Shin MG, Lee KS, Ahn DG. The encyclopedia of oriental herbal medicine. Seoul: Jungdam publishing group. 2004:3929-34.
22 McFarland KF, Catalano EW, Day JF, Thorpe SR, Baynes JW. Nonenzymatic glucosylation of serum proteins in diabetes mellitus. Diabetes. 1979;28:1011-4.   DOI
23 Momose T, Yano Y, Ohashi K. Organic analysis. XLIV. A new deproteinizing agent for determination of blood sugar. Chem. Pham. Bull. 1963;11: 968-72.   DOI
24 Nakayama H, Mitsuhashi T, Kuwajima S, Aoki S, Kuroda Y, Itoh Tet al. Chemical detection of advanced glycation endproducts in lens crystallins from streptozocin-induced diabetic rat. Diabetes. 1993;42:345-50.   DOI
25 Komatsu S. Extraction of nuclear proteins. Methods Mol. Biol. 2007;355:73-7.
26 Yokozawa T, Yamabe N, Kim HY, Kang KS, Hur JM, Park CH, et al. Protective effects of morroniside isolated from Corni Fructus against renal damage in streptozotocin-induced diabetic rats. Biol Pharm Bull. 2008;31:1422-8.   DOI
27 Al-Malki AL, Sayed AA, El Rabey HA. Proanthocyanidin attenuateion of oxidative stress and NF-${\kappa}$ B protects apolipoprotein E-deficient mice against diabetic nephropathy. Evidenc-Based Complementary and Alternative Medicine. 2013; 2013:1-8.
28 Rosen P, Nawroth PP, King G, Moller W, Tritschler HJ, Packer L. The role of oxidative stress in the onset and progression of diabetes and its complications: a summary of Congress Series sponsored by UNESCO-MCBN, the American Diabetes Association and the German Diabetes Society. Diabetes Metab Res Rev. 2001;17:189-212.   DOI
29 Ali SF, LeBel CP, Bondy SC. Reactive oxygen species formation as a biomarker of methylmercury and trimethyltin neurotoxicity. Neurotoxicology. 1992;13:637-48.
30 Newsolme P, Haber EP, Hirabara SM, Rebelato EL, Procopio J, Morgan D et al. Diabetes associated cell stress and dysfunction: role of mitochondrial and non-mitochondrial ROS production and activity. J. Physiol. 2007;583: 9-24.   DOI
31 Kashihara N, Haruna Y, Kondeti VK, Kanwar YS. Oxidative stress in diabetic nephropathy. Curr Med Chem. 2010;17:4256-69.   DOI
32 Tooke JE. Possible pathophysiological mechanisms for diabetic angiopathy in type 2 diabetes. J. Diabetes Complications. 2000;14:197-200.   DOI
33 Singh VP, Bali A, Singh N, Jaqqi AS. Advanced glycation endproducts and diabetic complications. Korean J Physiol Pharmacol. 2014;18:1-14.   DOI
34 Schinzel R, Munch G, Heidland A, Sebecova K. Advanced glycation endproducts in end-stage renal disease and their removal. Nephron. 2001; 87:295-303.   DOI
35 Horie K, Miyata T, Maeda K, Miyata S, Suqiyama S, Sakai H, et al. Immunohistochemical colocalization of glycoxidation products and lipid peroxidation products in diabetic renal glomerular lesions. Implications for glycoxidative stress in the pathogenesis of diabetic nephropathy. J. Clin Invest. 1997;100: 2995-3004.   DOI
36 Ceriello A, Bortolotti N, Pirisi M, Crescentini A, Tonutti L, Motz E, et al. Total plasma antioxidant capacity predicts thrombosis-prone status in NDDM patients. Diabetes Care. 1997; 20:1589-93.   DOI
37 Bierhaus A, Schiekofer S, Schwaninger M, Andrassy M, Humpert PM, Chen J, et al. Diabetes-associated sustained activation of the transcription factor nuclear factor-kappa B. Diabetes. 2001;50:2792-808.   DOI
38 Nagi R, Ikeda K, Higashi T, Sano H, Jinnouchi Y, Araki T, et al. Hydroxyl radical mediates N epsilon-(carboxymethyl)lysine formation from Amadori product. Biochem Biophys Res Commun. 1997;234:167-72.   DOI
39 Wells-Knecht KJ, Zyzak DV, Litchfield JE, Thorpe SR, Baynes JW. Mechanism of autoxidative glycosylation: identification of glyoxal and arabinose as intermediates in the autoxidative modification of proteins by glucose. Biochemistry. 1995;34:3702-9.   DOI
40 Nagi R, Unno Y, Hayashi MC, Masuda S, Hayase F, Kinae N, et al. Peroxynitrite induces formation of N(epsilon)-(carboxymethyl) lysine by the caleavage of Amadori product and generation of glucosone and glyoxal from glucose: novel pathways for protein modification by peroxynitrite. Diabetes. 2002;51:2833-89.   DOI
41 Koito W, Araki T, Horiuchi S, Nagai R. Conventional antibody against epsilon-(carboxymethyl) lysine (CML) shows cross-reaction to Nepsilon-(carboxyethyl)lysine (CEL): immnochemical quantification of CML with a specific antibody. J. Biochem. 2004;136:831-837.   DOI
42 Ahmed MU, Frye EB, Degenhardt TP, Thorpe SR, Baynes JW. Ne-(carboxyethyl)lysine, a product of the chemical modification of proteins by methylglyoxal, increase with age in human lens proteins. Biochem. J. 1997;324:565-70.   DOI
43 Lim AK, Tesch GH. Inflammation in diabetic nephropathy. Mediators Inflamm. 2012;2012: 1-12.
44 Lee JI, Burckart GJ. Nuclear factor kappa B: important transcription factor and therapeutic target. J. Clin. Pharmacol. 1998;38:981-93.   DOI
45 Baldwin AS Jr. NF-kappa B and I kappa B proteins: new discoveries and insights. Annu Rev Immunol. 1996;14:649-83.   DOI
46 Sanchez AP, Sharma K. Transcription factors in the pathogenesis of diabetic nephropathy. Expert Rev Mol Med. 2009;11:e13.   DOI